Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Nektar Therapeutics”

423 pharma patents match "Nektar Therapeutics" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 423
Index total 30,257
Page 4 / 18

Quick answer

This filtered view shows 423 pharmaceutical patents matching "Nektar Therapeutics" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

423 results for “Nektar Therapeutics” · 30,257 patents in full index Clear search

  1. US 10130720

    Composition comprising a polymeric reagent

    Nektar Therapeutics · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted
  2. US 10132810

    Method for assessing and predicting efficacy of breast cancer treatment with a long-acting topoisomerase I inhibitor

    Nektar Therapeutics · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted
  3. US 10098865

    Multi-arm polymeric prodrug conjugates of taxane-based compounds

    Nektar Therapeutics · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  4. US 10092656

    Protease inhibitors having enhanced features

    Nektar Therapeutics · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted
  5. US 10081602

    Opioid agonists and uses thereof

    Nektar Therapeutics · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  6. US 10039737

    Multi-arm polymeric alkanoate conjugates

    Nektar Therapeutics · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  7. US 10011682

    Method of preparing carboxylic acid functionalized polymers

    Nektar Therapeutics · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted
  8. US 10010587

    IL-2Rβ-selective agonists in combination with an anti-CTLA-4 antibody or an anti-PD-1 antibody

    Nektar Therapeutics · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted
  9. US 9999657

    Polymer-factor VIII moiety conjugates

    Nektar Therapeutics · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted
  10. US 9943605

    Polymer-semaxanib moiety conjugates

    Nektar Therapeutics · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted
  11. US 9937266

    Oligomer-containing benzamide-based compounds

    Nektar Therapeutics · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted
  12. US 9925182

    Compositions, dosage forms, and co-administration of an opioid agonist compound and an analgesic compound

    Nektar Therapeutics · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  13. US 9913913

    Method for preparing a polymeric reagent

    Nektar Therapeutics · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  14. US 9907855

    N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides

    Nektar Therapeutics · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  15. US 9908970

    Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method

    Nektar Therapeutics · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  16. US 9861705

    Conjugates of an IL-2 moiety and a polymer

    Nektar Therapeutics · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  17. US 9839695

    Polymer-active agent conjugate

    Nektar Therapeutics · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  18. US 9828465

    N-maleimidyl polymer derivatives

    Nektar Therapeutics · Granted Nov 28, 2017 · Expires Nov 23, 2037

    granted
  19. US 9827326

    Polymer-sunitinib conjugates

    Nektar Therapeutics · Granted Nov 28, 2017 · Expires Nov 23, 2037

    granted
  20. US 9827239

    Oligomer-opioid agonist conjugates

    Nektar Therapeutics · Granted Nov 28, 2017 · Expires Nov 23, 2037

    granted
  21. US 9815824

    Kappa opioid agonists and uses thereof

    Nektar Therapeutics · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  22. US 9808533

    Multi-arm polymer prodrugs

    Nektar Therapeutics · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted
  23. US 9801873

    Methods for treating humans having brain cancer

    Nektar Therapeutics · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted
  24. US 9782488

    Oligomer-beta blocker conjugates

    Nektar Therapeutics · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted